-
2023-506457-38-00
5
2024-06-05
Chronic kidney disease (CKD) and hypertension.
-
2023-505972-32-00
5
2024-02-26
locally advanced anal squamous cell carcinoma
-
2024-514878-53-00
4
2023-10-04
HMA-naïve, higher-risk (HR, defined as CPSS-mol risk intermediate-2 or
-
2022-501027-25-01
11
2023-06-01
Multiple Sclerosis
-
2023-506924-94-00
5
2023-02-28
Cardiovascular disease
-
2024-514480-26-00
4
2022-10-12
Post-menopausal women with localized luminal A breast cancer and consi
-
2023-507469-24-00
4
2022-04-30
Anemia in Patients with Very Low, Low, or Intermediate Risk Myelodyspl
-
2024-513936-80-00
4
2021-11-12
elderly patients (> 70 years) with CLL or SLL
-
2023-504684-16-00
5
2021-06-05
follicular lymphoma (FL) and marginal zone lymphoma (MZL)
-
2023-504830-23-00
5
2020-12-16
B-cell Lymphoma
-
2024-514088-25-00
5
2019-10-07
Multiple Myeloma
-
2024-513728-40-00
5
2019-07-02
scheduled surgery for digestive cancer
-
2022-500451-23-00
5
2019-03-18
Adults with a de novo glioblastoma
-
2024-512470-10-00
11
2018-02-02
End-stage Renal disease
-
2024-510704-37-00
5
2017-03-22
ER+/HER2- metastatic breast cancer
-
2024-514904-14-00
4
2014-10-08
Patients with metastatic or unresectable locally advanced malignancies
-
2024-516996-34-00
5
2012-04-12
oestrogen-receptor (ER)-positive HER2-negative breast carcinoma
-
2024-515171-35-00
5
2011-07-06
Prostatic adenocarnicoma with high risk of recurrence
-
2024-517036-21-00
4
2024-11-06
Coats' disease
-
2023-508958-26-00
7
2024-10-16
Gynaecological
-
2024-516793-30-00
5
2024-10-16
Thyroidectomy is a common operation. Transient postoperative hypocalce
-
2023-509001-76-00
5
2024-07-01
Asthma
-
2023-508663-70-00
4
2024-06-18
Bronchiectasis
-
2023-505108-52-00
5
2023-12-20
Intensive Care